A SXRF method for determining the relative concentration of trace elements in plasma protein affected by cisplatin.
This article presents an analytical method for the determination of the relative concentrations of trace elements in plasma protein by gel chromatography combined with SXRF (synchrotron radiation X-ray fluorescence). The fraction of plasma protein of male Kunming mice (body weight 24.2 +/- 0.3 g), treated with a cisplatin i.p. injection at a dose of 10 mg/kg, was obtained by the separation of a Sephadex G-50 column (buffered with ammonium acetate, pH 5.7). The SXRF experiments were performed at the Beijing Electron Positron Collider synchrotron radiation facility. The elements (Pt, S, Ca, Fe, Ni, Cu, Zn, Se, Br, and Sr) in the fraction of the plasma proteins (>22 kDa) were assayed using highly sensitive SXRF. The relative concentrations of elements were calculated by a normalization of Compton scattering intensity around 22 keV, after the normalization for the collection time of the X-ray spectrum and the counting of the ion chamber, and subtracting the contribution of the polycarbonate film for the supporting sample. The determination could prove that the element Pt in plasma was bound with macromolecular protein. Cu and S were present in the fraction of the protein in mice treated with cisplatin increase, and their ratios of treated/control were 1.66 +/- 0.06 and 1.78 +/- 0.33, respectively; Zn decreased to a ratio of 0.78 +/- 0.09. Our results are in agreement with others that cisplatin exposure leads to a marked loss of kidney copper and a moderate rise in kidney zinc. However, this article primarily describes one of the analytical methods used; it does not emphasize the results of the effect of cisplatin on trace elements in plasma protein.
Liu
N
N
Institute of High Energy Physics, Academia Sinica, Beijing, People's Republic of China.
Liu
P
P
Wang
K
K
Chen
D
D
Zhao
J
J
Xu
Q
Q
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001798:Blood Proteins / Q000737:chemistry* / Q000187:drug effects; D002850:Chromatography, Gel; D002945:Cisplatin / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D013052:Spectrometry, X-Ray Emission; D013056:Spectrophotometry, Ultraviolet; D017356:Synchrotrons; D014131:Trace Elements / Q000737:chemistry*
D000970:Antineoplastic Agents; D001798:Blood Proteins; D014131:Trace Elements; D002945:Cisplatin